Ligand · MON
MON · 4-(2-{[4-{[3-(4-chlorophenyl)propyl]sulfanyl}-6-(1-piperazinyl)-1,3,5-triazin-2-yl]amino}ethyl)phenol
MON, 4-(2-{[4-{[3-(4-chlorophenyl)propyl]sulfanyl}-6-(1-piperazinyl)-1,3,5-triazin-2-yl]amino}ethyl)phenol (C24 H29 Cl N6 O S, 485.1 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with…
- Component
- MON
- Formula
- C24 H29 Cl N6 O S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
MON in 2 structures; the first of them:
- 1NDE · Estrogen Receptor beta with Selective Triazine Modulator · MON A101 · binds MET295, LEU298, THR299, LEU301, ALA302, ASP303, GLU305, LEU306 and 18 more
- 1NDE · Estrogen receptor beta with selective triazine modulator · MON A101 · binds MET295, LEU298, THR299, LEU301, ALA302, ASP303, GLU305, LEU306 and 18 more
Residues it binds most
LEU 2, MET 2, GLY 2, ILE 2, PHE 2, ALA 2, ARG 2, ASP 2, GLU 2, HIS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.